Liminatus Pharma, Inc. LIMN
2.79 USD +0.21 (+8.35%)
At closeNov 3, 2026, 4:00 PM EST
2.77 -0.02 -0.72%
After hours · Nov 3, 4:00 PM ET
2.40 Day range 2.83
2.40 52-week range 141.50
- YTD
- -90.85%
- 1 year
- -95.77%
- Market cap
- 3.75M
- EPS (ttm)
- -23.50
- YTD return
- -90.85%
- 1-year return
- -95.77%
- Volume
- 44.85K
- Avg volume
- 215.42K
- Open
- 2.63
- Previous close
- 2.58
- Day's range
- 2.40 – 2.83
- 52-week range
- 2.40 – 141.50
1Y -60.77 (-95.70%)
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule 
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
Liminatus Pharma Engages Synex Consulting To Support Clinical Development Of IBC101, CD19xCD22 Bivalent CAR-T Cell Therapy Candidate 
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Liminatus Pharma Board Adopts Resolutions Approving Reverse Stock Split Of Its Common Stock At Ratio Of 1-For-50 
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock - 12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.